The sales of General Motors and Ford are greater than the gross domestic product of the whole of sub-Saharan Africa, and Wal-Mart now has a turnover higher than the revenues of most of the states of Eastern Europe. Yet few of us understand fully the growing dominance of big business.Widely acclaimed economist Noreena Hertz brilliantly reveals how corporations across the world manipulate and pressure governments by means both legal and illegal; how protest is becoming a more effective political weapon than the ballot-box; and how corporations are taking over from the state responsibility for everything from providing technology for schools to healthcare for the community.The Silent Takeover asks us to recognize the growing contradictions of a world divided between haves and have-nots, of gated communities next to ghettos, of extreme poverty and unbelievable wealth. In the face of these unacceptable extremes, Noreena Hertz outlines a new agenda to revitalize politics and renew democracy.

    But starting in the late 1990s, shocking reports emerged that showed this was far from the truth. Treatment-related deaths or “complications” were found to be the fifth leading cause of death for Americans, and hundreds of thousands of patients were being harmed by botched medical procedures.Spurred by the quality crisis, a group of visionary physicians led by Donald Berwick and Paul Batalden embarked on a study of industrial “quality improvement” techniques, daring to apply them to the practice of medicine despite resistance from the medical community. The Best Practice tells the story of this burgeoning movement, and of how the medical landscape is being radically transformed—for the better.

    

    This former senior VP of CIGNA explained how health insurers make promises they have no intention of keeping, how they flout regulations designed to protect consumers, and how they skew political debate with multibillion-dollar PR campaigns designed to spread disinformation.Potter had walked away from a six-figure salary and two decades as an insurance executive because he could no longer abide the routine practices of an industry where the needs of sick and suffering Americans take a backseat to the bottom line. The last straw: when he visited a rural health clinic and saw hundreds of people standing in line in the rain to receive treatment in stalls built for livestock.In Deadly Spin, Potter takes readers behind the scenes to show how a huge chunk of our absurd healthcare spending actually bankrolls a propaganda campaign and lobbying effort focused on protecting one thing: profits. Whatever the fate of the current health care legislation, it makes no attempt to change that fundamental problem. Potter shows how relentless PR assaults play an insidious role in our political process anywhere that corporate profits are at stake-from climate change to defense policy. Deadly Spin tells us why-and how-we must fight back.

     Small cap stocks are best for all time. Bunk! A trade deficit is bad for markets. Bunk! Stocks can't rise on high unemployment. Bunk! Many investors think they are safest following widely accepted Wall Street wisdom—but much of Wall Street wisdom isn't so wise. In fact, it can be costly bunk.In Debunkery: Learn It, Do It, and Profit From It—Seeing Through Wall Street's Money-Killing Myths, Ken Fisher—named one of the 30 most influential individuals of the last three decades by Investment Advisor magazine—details why so many investors fail to get the long-term results they desire. The short answer is many investors fail to question if what they believe is true—and are therefore blinded by tradition, biases, ideology, or any number of cognitive errors.Your goal as an investor shouldn't be to be error-free—that's impossible. Rather, to be more successful, you should aim to lower your error rate. Debunkery gets you started by debunking 50 common myths—but that's just the beginning. It also gives you the tools you need to continue to do your own debunkery for the rest of your investing career.

    But over the last fifty years, job security has cratered as the postwar institutions that insulated us from volatility--big unions, big corporations, powerful regulators--have been swept aside by a fervent belief in "the market." Temp tracks the surprising transformation of an ethos which favored long-term investment in work (and workers) to one promoting short-term returns. A series of deliberate decisions preceded the digital revolution and upended the longstanding understanding of what a corporation, or a factory, or a shop, was meant to do.Temp tells the story of the unmaking of American work through the experiences of those on the inside: consultants and executives, temps and office workers, line workers and migrant laborers. It begins in the sixties, with economists, consultants, business and policy leaders who began to shift the corporation from a provider of goods and services to one whose sole purpose was to maximize profit--an ideology that brought with it the risk-taking entrepreneur and the shareholder revolution and changed the very definition of a corporation.With Temp, Hyman explains one of the nation's most immediate crises. Uber are not the cause of insecurity and inequality in our country, and neither is the rest of the gig economy. The answer goes deeper than apps, further back than downsizing, and contests the most essential assumptions we have about how our businesses should work.

    She changed the way women thought about fashion and themselves; her dresses were meant to free women of the corset and allow them to move freely and elegantly. At the dawn of a new century, Chanel stood for a new type of woman.Chanel worked her way up from living in an orphanage to dining with royalty. She personified her own designs. Always independent, she never married, took on lovers as she pleased, and never apologized. A century after Coco Chanel opened her first small shop in Paris, her designs still define luxury.Discover a plethora of topics such asAn Orphaned GirlCoco Takes on ParisChanel No. 5The Crash of 1929Chanel during World War II: The Nazi SpyExile and ReturnAnd much more!

    But the left and right can usually agree on one thing: that the Nordic system is impossible to replicate here at home. The US is too big, or too individualistic, or too puritan, or too . . . something. Whatever the reason, it's impossible, and we shouldn't bother to try.Enter George Lakey. A longtime activist and academic, Lakey has spent decades studying the economies of Denmark, Sweden, Norway, Finland, and Iceland, and in Viking Economics, he reveals that Scandinavia's deep commitment to the welfare state is much more recent than we think. Not long ago, Scandinavia was a far more unequal place, with a much weaker commitment to the social welfare of its citizens. There's nothing inherently Scandinavian about greater equality . . . so why not try it here?Viking Economics is more fun and entertaining than any economics book you've ever read. And, very possibly, more convincing! As he ranges from twentieth-century Norwegian history to the details of Swedish childcare policies, Lakey never loses his sense of humor or his expansive, generous vision of a better, more equal future. By explaining that even Scandinavia's grandest experiments in social equality are rooted in recent political struggles, Lakey explains shows how we can do it, too—conventional wisdom be damned.From the Hardcover edition.

    Researchers are delving into the mysteries of stem cells and the human genome, discovering what it means to grow old and how to keep those processes from happening. This isn't science fiction; it's real, it's serious, and it's on track to revolutionize our definitions of life and mortality.In Immortality, Inc., veteran science journalist Chip Walter gains exclusive access to the champions of this radical cause, delivering a book that brings together for the first time the visions of molecular biologist and Apple chairman Arthur Levinson, genomics entrepreneur Craig Venter, futurist Ray Kurzweil, rejuvenation trailblazer Aubrey de Grey, and stem cell expert Robert Hariri. Along the way, Walter weaves in fascinating conversations about life, death, aging, and the future of the human race.

    is the first deep-dive investigation of a hazardous and illicit industry that has created a worldwide epidemic, ravaging communities and overwhelming and confounding government agencies that are challenged to combat it. "A whole new crop of chemicals is radically changing the recreational drug landscape," writes Ben Westhoff. "These are known as Novel Psychoactive Substances (NPS) and they include replacements for known drugs like heroin, cocaine, ecstasy, and marijuana. They are synthetic, made in a laboratory, and are much more potent than traditional drugs"--and all-too-often tragically lethal. Drugs like fentanyl, K2, and Spice--and those with arcane acronyms like 25i-NBOMe-- were all originally conceived in legitimate laboratories for proper scientific and medicinal purposes. Their formulas were then hijacked and manufactured by rogue chemists, largely in China, who change their molecular structures to stay ahead of the law, making the drugs' effects impossible to predict. Westhoff has infiltrated this shadowy world, becoming the first journalist to report from inside an illicit Chinese fentanyls lab and providing startling and original reporting on how China's vast chemical industry operates, and how the Chinese government subsidizes it. He tracks down the little-known scientists who invented these drugs and inadvertently killed thousands, as well as a mysterious drug baron who turned the law upside down in his home country of New Zealand. Poignantly, Westhoff chronicles the lives of addicted users and dealers, families of victims, law enforcement officers, and underground drug awareness organizers in the U.S. and Europe. Together they represent the shocking and riveting full anatomy of a calamity we are just beginning to understand. From its depths, as Westhoff relates, are emerging new strategies that may provide essential long-term solutions to the drug crisis that has affected so many.

    But are its analyses of inequality and economic growth on target? Where should researchers go from here in exploring the ideas Piketty pushed to the forefront of global conversation? A cast of economists and other social scientists tackle these questions in dialogue with Piketty, in what is sure to be a much-debated book in its own right.After Piketty opens with a discussion by Arthur Goldhammer, the book's translator, of the reasons for Capital's phenomenal success, followed by the published reviews of Nobel laureates Paul Krugman and Robert Solow. The rest of the book is devoted to newly commissioned essays that interrogate Piketty's arguments. Suresh Naidu and other contributors ask whether Piketty said enough about power, slavery, and the complex nature of capital. Laura Tyson and Michael Spence consider the impact of technology on inequality. Heather Boushey, Branko Milanovic, and others consider topics ranging from gender to trends in the global South. Emmanuel Saez lays out an agenda for future research on inequality, while a variety of essayists examine the book's implications for the social sciences more broadly. Piketty replies to these questions in a substantial concluding chapter.An indispensable interdisciplinary work, After Piketty does not shy away from the seemingly intractable problems that made Capital in the Twenty-First Century so compelling for so many.

    Healy, who was the first to draw attention to the now well-publicized suicide-inducing side effects of many anti-depressants, attributes our current state of affairs to three key factors: product rather than process patents on drugs, the classification of certain drugs as prescription-only, and industry-controlled drug trials. These developments have tied the survival of pharmaceutical companies to the development of blockbuster drugs, so that they must overhype benefits and deny real hazards. Healy further explains why these trends have basically ended the possibility of universal health care in the United States and elsewhere around the world. He concludes with suggestions for reform of our currently corrupted evidence-based medical system.

    And you have no idea what you signed up for. Or maybe you've been a stepmom for a while now, but things are getting you down. Who do you turn to for help? Where is the stepmothering support group that'll give you the advice you need? Who actually gets how hard being a stepmom can be?We do. We are the women who have chosen stepmotherhood and lived to tell the tale. This guide holds our solutions to help you:- Brave the crazy ex demands- Overcome the financial hurdles of a blended family- Be prepared for the legal battles and custody arrangements- Handle disrespectful children- Nourish your relationship- Manuever the emotional breakdowns of stepmotherhood- Build your own stepmom's club- Understand why you need your partner to have your backWritten by stepmoms for stepmoms, these tips, anecdotes, and words of advance will help you find success and support within your new family.We are the Stepmoms' Club --your club --and we're here to help you.

    Chinese airlines expect to triple their fleet size over the next decade and will account for the fastest-growing market for Boeing and Airbus. But the Chinese are determined to be more than customers. In 2011, China announced its Twelfth Five-Year Plan, which included the commitment to spend a quarter of a trillion dollars to jump-start its aerospace industry. Its goal is to produce the Boeings and Airbuses of the future. Toward that end, it acquired two American companies: Cirrus Aviation, maker of the world’s most popular small propeller plane, and Teledyne Continental, which produces the engines for Cirrus and other small aircraft. In China Airborne, James Fallows documents, for the first time, the extraordinary scale of this project and explains why it is a crucial test case for China’s hopes for modernization and innovation in other industries. He makes clear how it stands to catalyze the nation’s hyper-growth and hyper- urbanization, revolutionizing China in ways analogous to the building of America’s transcontinental railroad in the nineteenth century. Fallows chronicles life in the city of Xi’an, home to more than 250,000 aerospace engineers and assembly workers, and introduces us to some of the hucksters, visionaries, entrepreneurs, and dreamers who seek to benefit from China’s pursuit of aerospace supremacy. He concludes by examining what this latest demonstration of Chinese ambition means for the United States and the rest of the world—and the right ways to understand it.

    Gerard, PhD, its chief learning officer, candidly describe the triumphs and stumbles of a seven-year journey to lean healthcare, an effort that continues today and that has slashed medical errors, improved patient outcomes, raised staff morale, and saved $27 million dollars in costs without layoffs. Find out:> How lean techniques of value-stream-mapping and rapid improvement events cut the average “door-to-balloon” time for heart attack patients at two hospitals from 90 minutes to 37.> What ThedaCare leaders did to replace medicine’s “shame and blame” culture with a lean culture based on continuous improvement and respect for people.> How the lean principle of “building in quality at the source” broke down divisions among medical specialties allowing teams to develop patient care plans faster.> Why traditional modern management is the single biggest impediment to lean healthcare.> How the plan-do-study-act cycle coupled with rapid improvement events cut the wait time at a robotic radiosurgery unit from 26 days to six.> How the lean concept of “one piece flow” saved time in treating ischemic stroke patients, increasing the number of patients receiving a CT scan within 25 minutes from 51% to 89%.> How senior leaders at other healthcare organizations can begin their own lean transformations using a nine-step action plan based on what ThedaCare did — and what it would do differently.Toussaint and Gerard prove that lean healthcare does not mean less care. On the Mend shows that when care is truly re-designed around patients, waste and errors are eliminated, quality improves, costs come down, and healthcare professionals have more time to spend with patients, who get even better care.